Delivery Order SPE2DX22D0010-SPE2D825FHP36
- Not listed
- The Defense Logistics Agency awarded a $1,837.56 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a completion deadline of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award carries no set-aside designation, indicating it was competitively awarded. Performance will occur at the vendor's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Nucynta ER (tapentadol extended-release) 100mg tablets, valued at $6,005.43. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 5, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,288.63 on July 25, 2025, for the supply of Nucynta Tabs 50mg under a firm fixed price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by July 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units, with a ceiling value of $1,225.04. This firm fixed-price delivery order is scheduled for completion by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,891.14 to AmerisourceBergen Drug Corp for Nucynta ER Tabs 200mg on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a pediatric procurement under a non-competitive set-aside status and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $2,004.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Nucynta ER 100 mg tablets (60-count). This contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order was competitively awarded with no set-aside designation and is scheduled for completion by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,225.04 and an ultimate completion date of August 6, 2025. The award represents a non-competitive action under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units under a firm fixed-price contract with a ceiling value of $1,225.04. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, non-set-aside procurement. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,837.60 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Nucynta 50 mg tablets (100-count packages). This firm fixed-price contract, which is not set-aside and competitively awarded, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date...
- AmerisourceBergen Drug Corp received a delivery order award on July 25, 2025, for the supply of Nucynta ER 100 mg tablets (60-count) valued at $4,045.62. The award is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive, non-set-aside contract. The place of performance is AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHP36Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $4,442.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nucynta (tapentadol) 50mg tablets. This non-set-aside delivery order, with an ultimate completion date of August 12, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, demonstrating significant capability to fulfill federal medical procurement requirements through competitive award processes. AmerisourceBergen holds a substantial $999.99 billion IDC with DLA Troop Support Medical through December 2026, which functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Nucynta reflects the company's role in providing pain management pharmaceuticals to federal healthcare systems, consistent with its extensive portfolio of brand-name and generic medications supplied to the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/11/25 |